If you are unfamiliar with digital therapeutics, simply put it is a health specialty and treatment alternative that uses enhanced, bespoke technology and applications to treat and manage a range of medical and psychological conditions. Unlike more traditional methods, digital therapeutics often relies heavily on the patient’s behavioral and lifestyle changes coupled with remote support and access to data, progress reports, guidance, and feedback.
Digital therapeutics and their advantages have recently stormed into the mainstream, especially due to the COVID-19 pandemic and extended lockdowns across the globe. The popularity of this remote style of treatment has been by no means unprecedented, as its practicality, convenience, and cost-effective benefits are now staunchly intertwined with modern-day medicine.
Better Therapeutics was founded on the progressive theory that digitally delivered cognitive behavioral therapy can facilitate patients by creating change around the root causes of conditions such as diabetes and heart disease.
Dealing primarily with cardiometabolic disorders, Better Therapeutics are striving to alter the paradigm of remedies for millions of sufferers.
By creating new treatments to combat the progression of diseases, bolster quality of life and guide mainstream clinical decisions, Better Therapeutics’ patented methods aim to reduce or eliminate the need for ongoing medications, publicize the gains of prescribed behavioral therapy, add to essential ongoing data collection, provide access to solutions, and reduce the overall global cost of care.
With an increasing number of patients, doctors, and medical insurers becoming familiar with and utilizing digitally delivered assistance, Better Therapeutics are ideally positioned to be at the forefront of revolutionizing the way in which most widespread conditions are treated.